Cargando…
Formulation of a mmaA4 Gene Deletion Mutant of Mycobacterium bovis BCG in Cationic Liposomes Significantly Enhances Protection against Tuberculosis
A new vaccination strategy is urgently needed for improved control of the global tuberculosis (TB) epidemic. Using a mouse aerosol Mycobacterium tuberculosis challenge model, we investigated the protective efficacy of a mmaA4 gene deletion mutant of Mycobacterium bovis BCG (ΔmmaA4BCG) formulated in...
Autores principales: | Derrick, Steven C., Dao, Dee, Yang, Amy, Kolibab, Kris, Jacobs, William R., Morris, Sheldon L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307709/ https://www.ncbi.nlm.nih.gov/pubmed/22442674 http://dx.doi.org/10.1371/journal.pone.0032959 |
Ejemplares similares
-
Mycolic Acid Modification by the mmaA4 Gene of M. tuberculosis Modulates IL-12 Production
por: Dao, Dee N., et al.
Publicado: (2008) -
Fragment-Based Ligand Discovery Applied to the Mycolic Acid Methyltransferase Hma (MmaA4) from Mycobacterium tuberculosis: A Crystallographic and Molecular Modelling Study
por: Galy, Romain, et al.
Publicado: (2021) -
Vaccination-related Mycobacterium bovis BCG Infection
por: Liberek, Anna, et al.
Publicado: (2006) -
Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives
por: Dellagostin, Odir Antônio, et al.
Publicado: (2022) -
Biochemical characterization of the maltokinase from Mycobacterium bovis BCG
por: Mendes, Vítor, et al.
Publicado: (2010)